- Home
- HSTM vs COLL Comparison
HSTM vs COLL Comparison
Compare HSTM & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSTM
- COLL
- Stock Information
- Founded
- HSTM 1990
- COLL 2002
- Country
- HSTM United States
- COLL United States
- Employees
- HSTM N/A
- COLL N/A
- Industry
- HSTM Computer Software: Programming Data Processing
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- HSTM Technology
- COLL Health Care
- Exchange
- HSTM Nasdaq
- COLL Nasdaq
- Market Cap
- HSTM 960.2M
- COLL 864.7M
- IPO Year
- HSTM 2000
- COLL 2015
- Fundamental
- Price
- HSTM $27.23
- COLL $27.27
- Analyst Decision
- HSTM Hold
- COLL Strong Buy
- Analyst Count
- HSTM 2
- COLL 5
- Target Price
- HSTM $30.00
- COLL $43.60
- AVG Volume (30 Days)
- HSTM 174.2K
- COLL 340.0K
- Earning Date
- HSTM 05-05-2025
- COLL 05-08-2025
- Dividend Yield
- HSTM 0.45%
- COLL N/A
- EPS Growth
- HSTM 32.31
- COLL 43.56
- EPS
- HSTM 0.66
- COLL 1.86
- Revenue
- HSTM $291,646,000.00
- COLL $631,449,000.00
- Revenue This Year
- HSTM $6.54
- COLL $19.96
- Revenue Next Year
- HSTM $5.26
- COLL $3.93
- P/E Ratio
- HSTM $40.82
- COLL $14.69
- Revenue Growth
- HSTM 4.51
- COLL 11.41
- 52 Week Low
- HSTM $25.91
- COLL $23.23
- 52 Week High
- HSTM $34.24
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- HSTM 28.38
- COLL 48.29
- Support Level
- HSTM $25.84
- COLL $26.72
- Resistance Level
- HSTM $34.13
- COLL $27.70
- Average True Range (ATR)
- HSTM 0.92
- COLL 0.97
- MACD
- HSTM -0.71
- COLL 0.15
- Stochastic Oscillator
- HSTM 16.77
- COLL 60.43
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.